Information Request Form

Section:	Main.PSYCHIATRY.Depression.Treatment.Methylphenidate (CNS Stimulant)..Enantiomer..(S,S)-Enantiomer..(L-Threo-Methylphenidate)..Patent.Literature.Claim 1: Depression Treat. Method.WithOut Dysphoria: Adm.:.L-Threo-Methylphenidate. Purity >.95%. Claim 2: Non-Oral Adm.:.IntraVenous. Oral Adm.: SubLingual.Claim 5: Depression Treat. Method.(a) Non-Oral Adm. of L-Threo.Methylphenidate & (b) Oral Adm. of.Conventional Anti-Depressant (II).Claim 6: (II): Serotonin Reuptake.Inhibitor; Atypical Antidepressant.or TriCyclic Antidepressant..Claim 7: Serotonin Reuptake Inhib..Select: Fluoxetine, Fluvoxamine,.Paroxetine, Sertraline, Venlafaxine.Claim 8: Atypical Antidepressant is.Nefazodone or Buproprion..Claim 9: TriCyclic Antidepressant.Select: Amitriptyline, Imipramine,.Doxepin, Maprotiline, Etc..Patent Assignee
Code:	52392
Product:	Bermudas. P
Company or Organization:
Contact's name *:
Position:
E-mail:
Mailing address:
Phone number:
Fax number:
Fields of interest:	PATENT ASSIGNEE PATENT INVENTORS PATENT NUMBER
* If you are not linked to any company or organization complete at least this field